Home > Ammonium hexafluorozirconate > Ammonium hexafluorozirconate(16919-31-6)
Ammonium hexafluorozirconate(16919-31-6)
Supplier Product Identification
Physical and Chemical Properties
First Aid Measures
Handling and Storage
Hazards Identification
Exposure Controls/Personal Protection
Fire Fighting Measures
Accidental Release Measures
Stability and Reactivity
Product Identification
Product Name
Ammonium hexafluorozirconate
Ammonium hexafluorozirconate
Synonyms
Ammonium fluozirconate
Ammonium hexafluorozirconate
Ammonium fluozirconate
Ammonium hexafluorozirconate
CAS
16919-31-6
16919-31-6
Formula
F6H8N2Zr
F6H8N2Zr
Molecular Weight
241.28
241.28
EINECS
240-970-4
240-970-4
Beilstein/Gmelin
42184 (G)
42184 (G)
Physical and Chemical Properties
Appearance
Rhombic, hexagonal crystals.
Rhombic, hexagonal crystals.
Solubility in water
soluble
soluble
Density
1.154 g/cm3 (20 C)
1.154 g/cm3 (20 C)
Usage
Medication.
Medication.
First Aid Measures
Ingestion
Administer milk, calcium gluconate, or calcium lactate to bind fluoride ion in the gastrointestinal tract. Antacids (aluminum and/or magnesium based) should be administered. Iv calcium (gluconate or chloride) and magnesium may be necessary to correct serum deficits of these divalent metals in serious overdosage. Monitor ekg and vital signs.
Administer milk, calcium gluconate, or calcium lactate to bind fluoride ion in the gastrointestinal tract. Antacids (aluminum and/or magnesium based) should be administered. Iv calcium (gluconate or chloride) and magnesium may be necessary to correct serum deficits of these divalent metals in serious overdosage. Monitor ekg and vital signs.
Inhalation
Move patient to fresh air. Monitor for respiratory distress. If cough or difficulty breathing develops, evaluate for respiratory tract irritation, bronchitis, or pneumonitis. Administer oxygen and assist ventilation as required. Treat bronchospasm with beta2 agonist and corticosteroid aerosols.
Move patient to fresh air. Monitor for respiratory distress. If cough or difficulty breathing develops, evaluate for respiratory tract irritation, bronchitis, or pneumonitis. Administer oxygen and assist ventilation as required. Treat bronchospasm with beta2 agonist and corticosteroid aerosols.
Skin
Remove contaminated clothing and wash exposed area thoroughly with soap and water. A physician should examine the area if irritation or pain persists.
Remove contaminated clothing and wash exposed area thoroughly with soap and water. A physician should examine the area if irritation or pain persists.
Eyes
Irrigate exposed eyes with copious amounts of tepid water for at least 15 minutes. If irritation, pain, swelling, lacrimation, or photophobia persist, the patient should be seen in a health care facility.
Irrigate exposed eyes with copious amounts of tepid water for at least 15 minutes. If irritation, pain, swelling, lacrimation, or photophobia persist, the patient should be seen in a health care facility.
Handling and Storage
Storage
Keep in a cool, dry, dark location in a tightly sealed container or cylinder. Keep away from incompatible materials, ignition sources and untrained individuals. Secure and label area. Protect containers/cylinders from physical damage.
Keep in a cool, dry, dark location in a tightly sealed container or cylinder. Keep away from incompatible materials, ignition sources and untrained individuals. Secure and label area. Protect containers/cylinders from physical damage.
Handling
All chemicals should be considered hazardous. Avoid direct physical contact. Use appropriate, approved safety equipment. Untrained individuals should not handle this chemical or its container. Handling should occur in a chemical fume hood.
All chemicals should be considered hazardous. Avoid direct physical contact. Use appropriate, approved safety equipment. Untrained individuals should not handle this chemical or its container. Handling should occur in a chemical fume hood.
Hazards Identification
Inhalation
Respirations are first stimulated then depressed. Death is usually from respiratory paralysis. Following inhalation, coughing and choking may be noted.
Respirations are first stimulated then depressed. Death is usually from respiratory paralysis. Following inhalation, coughing and choking may be noted.
Skin
Urticaria and pruritus have been reported following exposure to fluoride.
Urticaria and pruritus have been reported following exposure to fluoride.
Ingestion
Epigastric pain, nausea, dysphagia, salivation, hematemesis, and diarrhea may be noted. These effects may be delayed for several hours following exposure. Gi symptoms are noted when 3 to 5 mg/kg of fluoride are ingested.
Epigastric pain, nausea, dysphagia, salivation, hematemesis, and diarrhea may be noted. These effects may be delayed for several hours following exposure. Gi symptoms are noted when 3 to 5 mg/kg of fluoride are ingested.
Exposure Controls/Personal Protection
Personal Protection
Chemical splash goggles in compliance with OSHA regulations are advised; however, OSHA regulations also permit other type safety glasses. Whre chemical resistant gloves. To prevent repeated or prolonged skin contact, wear impervious clothing and boots.
Chemical splash goggles in compliance with OSHA regulations are advised; however, OSHA regulations also permit other type safety glasses. Whre chemical resistant gloves. To prevent repeated or prolonged skin contact, wear impervious clothing and boots.
Respirators
Use NIOSH/MSHA approved respirator appropriate for exposure of concern.
Use NIOSH/MSHA approved respirator appropriate for exposure of concern.
Exposure Effects
Hyperactive reflexes, painful muscle spasms, weakness and tetanic contractures may be noted due to fluoride induced hypocalcemia. Prenatal fluoride supplementation (2.2 mg NaF or 1 mg fluoride daily) during the last two trimesters of pregnancy has been reported to be safe.
Hyperactive reflexes, painful muscle spasms, weakness and tetanic contractures may be noted due to fluoride induced hypocalcemia. Prenatal fluoride supplementation (2.2 mg NaF or 1 mg fluoride daily) during the last two trimesters of pregnancy has been reported to be safe.
Exposure limit(s)
IDHL: 500 mg/m3
IDHL: 500 mg/m3
Fire Fighting Measures
Fire Fighting
Wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Use agent most appropriate to extinguish fire.
Wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Use agent most appropriate to extinguish fire.
Accidental Release Measures
Small spills/leaks
Evacuate area and ventilate. Wear protective equipment. If required, use an inert absrobent. Sweep up and place in an appropriate container for disposal. Wash contaminated surfaces.
Evacuate area and ventilate. Wear protective equipment. If required, use an inert absrobent. Sweep up and place in an appropriate container for disposal. Wash contaminated surfaces.
Stability and Reactivity
Stability
No data.
No data.
Incompatibilities
Strong oxidizing agents.
Strong oxidizing agents.
Contact
More
- Company Name:future industrial shanghai co., ltd
- Tel:400-0066400 13621662912
- Fax:021-55660885
- WebSite:http://www.jonln.com
- Company Name:Beijing HwrkChemical Technology Co., Ltd
- Tel:010-89508211 18501085097
- Fax:010-89508210
- WebSite:http://www.hwrkchemical.com
- Company Name:Energy Chemical
- Tel:021-021-58432009 400-005-6266
- Fax:021-58436166
- WebSite:http://www.energy-chemical.com
- Company Name:Shanghai Mintchem Development Co., Ltd
- Tel:021 6845 0923
- Fax:0086 20 8234 8082
- WebSite:http://www.mintchem.com/
- Company Name:Shandong Xiya Chemical Co., Ltd
- Tel:4009903999 13355009207
- Fax:0539-6365991
- WebSite:http://www.xiyashiji.com